PB Fintech Limited (NSE:POLICYBZR)
India
· Delayed Price · Currency is INR | Market Cap | 713.58B |
| Revenue (ttm) | 45.59B |
| Net Income (ttm) | 2.43B |
| Shares Out | 456.62M |
| EPS (ttm) | 5.23 |
| PE Ratio | 299.07 |
| Forward PE | 92.44 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,383,747 |
| Average Volume | 1,598,695 |
| Open | 1,510.10 |
| Previous Close | 1,509.00 |
| Day's Range | 1,510.10 - 1,575.55 |
| 52-Week Range | 1,017.55 - 2,246.90 |
| Beta | 0.48 |
| RSI | 42.11 |
| Earnings Date | Jan 29, 2025 |
About PB Fintech
PB Fintech Limited operates an online platform for insurance and lending products in India and internationally. It operates through two segments Insurance Services and Other Services. The company offers Policybazaar, an online platform to buy and sell insurance products, such as health, term, motor, and travel insurance products; savings and investment products; and B2B offerings for consumers and insurance partners. It also provides Paisabazaar, an independent digital lending platform that enables consumers to compare, choose, and apply for pe... [Read more]
Financial Performance
Financial StatementsNews
We are building secured lending and savings to minimize risks: PB Fintech CEO
Yashish Dahiya, Chairman and Group CEO of PB Fintech talks about business outlook.
PB Fintech shares rise 3% as HSBC maintains ‘Buy’ with Target Price of Rs 2,530 per share
Shares of PB Fintech Ltd rose 3% on January 31, trading at ₹1,703.75, up ₹47.65 from the previous close of ₹1,656.10. The stock saw a day range between ₹1,595.10 and ₹1,708.70, with a market capitaliz...
PB Fintech Q3FY25 results: Revenue rises 48% YoY to Rs 1,292 crore, net profit up 92% to Rs 72 crore
Core insurance revenue grew 45% YoY, driven by health insurance outpacing other segments. The renewal/trail revenue reached an annualized run rate (ARR) of ₹665 crore, marking a 46% increase from ₹454...
Union Budget 2025: PB Fintech President Rajiv Gupta urges tax reforms to boost insurance penetration and retirement planning
With the Union Budget 2025 approaching, Rajiv Gupta, President of PB Fintech, outlined key expectations to advance the insurance sector’s goal of achieving universal coverage by 2047. Gupta emphasized...
Policybazaar parent to invest Rs 860 crore for 25% in PB Health
PB Fintech's Policybazaar is investing Rs 860 crore for a 25% stake in PB Healthcare to develop hospitals with a 1,000-bed capacity. These hospitals aim to offer zero rejection and cashless treatment....
PB Fintech shares surge over 5% as Citi reaffirms ‘buy’ rating with target price of Rs 2000, suggesting 24% upside
Shares of PB Fintech Ltd., the parent company of Policybazaar, climbed over 5% on Tuesday, January 23, following a positive outlook from Citi. The brokerage firm placed the stock on a 90-day positive ...
Paytm vs PB Fintech: Which stock delivered better returns over 1-month, 6-month, and 1-year?
The fintech sector features two notable players, Paytm (One 97 Communications Ltd) and PB Fintech Ltd (Policybazaar), both of which have shown varying trends over the past month, six months, and one y...
This fintech stock slides 20% in one month but nearly doubles investor wealth in one year – check details
Shares of PB Fintech Ltd, the parent company of Policybazaar, have recorded a decline of 19.96% over the past month, closing at ₹1,719 as of January 17, 2025. However, the stock has delivered a notabl...
PB Fintech shares fall over 6% as Morgan Stanley downgrades stock to ‘Underweight’
Shares of PB Fintech Ltd, the parent company of Policybazaar, dropped over 6% today, trading at ₹1,749.20 as of early market hours. The decline follows a downgrade by Morgan Stanley from ‘Equal Weight...
Macquarie revises outlook on financial stocks: LIC, ICICI Lombard upgraded; SBI Life, PB Fintech downgraded
Macquarie has updated its outlook on the financial sector, delivering both upgrades and downgrades on key stocks while maintaining a selective stance on the sector. Here’s a breakdown of their latest ...
Morgan Stanley on PB Fintech: Downgrade to underweight, check target share price here
Morgan Stanley has downgraded PB Fintech to underweight from equal weight, citing concerns over valuation and profit emergence. The brokerage has set a target price of ₹1,400, representing a significa...
Macquarie Downgrades SBI Life, PB Fintech; upgrades LIC and ICICI Lombard
Macquarie has issued its latest outlook on the financial sector, downgrading SBI Life Insurance from “Overweight” to “Neutral” with a reduced target price of ₹1,435 (previously ₹1,830) and PB Fintech ...
Nifty Midcap Falls: Dixon Tech down 7.60%, Oracle down 4.30%, PB Fintech down 4%
The Nifty Midcap 50 index witnessed a sharp decline today, falling by 1.56% or 247.35 points to settle at 15,620.70. The index saw broad-based selling across sectors, with Engineering, Manufacturing, ...
Top gainers this morning: Bajaj Finance up 3.46%, Maruti Suzuki up 2%, Vishal Mega Mart up 4% and more
The Indian stock market witnessed a positive opening today, with several large-cap stocks showing strong upward momentum. Financial and auto sectors have taken the lead, reflecting investor optimism a...
HSBC initiates Buy call on PB Fintech, expects stock to rally 16% from current price
HSBC has initiated coverage on PB Fintech, India's largest online insurance marketplace, with a Buy rating and a target price of ₹2,550, implying a 16% upside in the stock price from current levels.
PB Fintech’s (Policybazaar) shares surge over 22% this week – Know more
Shares of PB Fintech Ltd. saw a significant jump of 22.61% this week, closing at ₹2,142.30 on December 6, 2024. The stock gained ₹124.90 during Friday’s session, continuing its upward trend from earli...
BofA maintains ‘Neutral’ on PB Fintech, target price for stock at ₹1,850
Bank of America (BofA) has reiterated its 'Neutral' rating on PB Fintech with a target price of ₹1,850, citing strong core momentum in its business.
PB Fintech: Stock closes 12.3% below 52-week high, 137.9% above 52-week low
PB Fintech (NSE: PBFINTECH) ended trading on November 14, 2024, at ₹1,727.40, reflecting a gain of 5.79%. The stock remains 12.3% below its 52-week high of ₹1,966.50 and 137.9% above its 52-week low o...
UBS downgrades PB Fintech to ‘Sell’ with 7% downside from current market price
UBS has downgraded PB Fintech from ‘Neutral’ to ‘Sell,’ setting a revised target price of ₹1,550, indicating a potential 7% downside from the current market price (CMP) of ₹1,670.80. Key insights from...
Investec maintains buy on PB Fintech, sees 8% upside; target price at Rs 1,750
Investec has reiterated its buy rating on PB Fintech, setting a target price of ₹1,750, which indicates an 8% upside from the current market price of ₹1,627. The brokerage highlighted strong revenue g...
Policy Bazaar Share: Morgan Stanley maintains equal-weight on PB Fintech with target of Rs 1,375, sees 15% downside
Morgan Stanley has maintained its equal-weight rating on PB Fintech, setting a target price of ₹1,375, indicating a potential downside of 15% from the current market price of ₹1,627. The company poste...
PB Fintech Q2 FY25 results: Stock drops 2% ahead of result announcement
In early trading today, shares of PB Fintech declined over 2%, opening at ₹1,700.50 and reaching a high of ₹1,712.05. The stock hit a low of ₹1,660.00, reflecting investor caution as the company prepa...
PB Fintech subsidiary granted certificate of registration by RBI to operate as account aggregator
PB Fintech Limited, the parent company of Policybazaar, announced that its wholly owned subsidiary, PB Financial Account Aggregators Private Limited, has been granted a Certificate of Registration (Co...
Bernstein on PB Fintech: Expects 4% upside, maintains Outperform rating
Bernstein has maintained its Outperform rating on PB Fintech, setting a target price of Rs 1720, implying an upside potential of around 4% from the current market price of Rs 1,654. The brokerage firm...
Major Block Trades Today: Mahindra & Mahindra ₹168.49 crore, PB Fintech ₹150.85 crore, Max Healthcare ₹95.05 crore
Several large block trades took place on the NSE today, involving major companies like Mahindra & Mahindra, Max Healthcare Institute, and PB Fintech. Here are the key details: Max Healthcare Institute...